All posts by medical

Nano-sized vesicles with ACE2 receptor could prevent, treat infection from current and future strains of SARS-CoV-2 – EurekAlert

image:Raghu Kalluri, M.D., Ph.D. view more

Credit: MD Anderson Cancer Center

HOUSTON and CHICAGO Scientists at The University of Texas MDAnderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

The evACE2 act as decoys in the body and can serve as a therapeutic to be developed for prevention and treatment for current and future strains of SARS-CoV-2 and subsequent coronaviruses, the scientists report. Once developed as a therapeutic product, evACE2 have the potential to benefit humans as a biological treatment with minimal toxicities.

The study is the first to show evACE2 are capable of fighting the new SARS-CoV-2 variants with an equal or better efficacy than blocking the original strain. The researchers found that evACE2 exist in human blood as a natural anti-viral response. The more severe, the higher the levels of evACE2 detected in the patients blood.

Whenever a new mutant strain of SARS-CoV-2 surges, the original vaccine and therapeutic antibodies may lose power against alpha, beta, delta and the most recent, omicron, said co-senior author Huiping Liu, M.D., Ph.D., associate professor of pharmacology and medicine at Northwestern University Feinberg School of Medicine. However, the beauty of evACE2 is its superpower in blocking broad strains of coronaviruses, including current SARS-CoV-2 and even future SARS coronaviruses from infecting humans. Our mouse studies demonstrate the therapeutic potential of evACE2 in preventing or blocking SARS-CoV-2 infection when it is delivered to the airway via droplets.

The evACE2 are tiny lipid bubbles in nanoparticle size that express the ACE2 protein, like handles for the virus to grab. These vesicles act as decoys to lure the SARS-CoV-2 virus away from the ACE2 protein on cells, which is how the virus infects cells. The virus spike protein grabs evACE2 instead of cellular ACE2, preventing it from entering the cell. Once captured, the virus will either float harmlessly around or be cleared by a macrophage immune cell. It can no longer cause infection.

"The key takeaway from this study is the identification of naturally occurring extracellular vesicles in the body that express the ACE2 receptor on their surface and serve as part of the normal adaptive defense against COVID-19-causing viruses," said co-senior author Raghu Kalluri, M.D., Ph.D., chair of Cancer Biology at MD Anderson. "Building upon this, we've discovered a way to harness this natural defense as a new potential therapy against this devastating virus."

The COVID-19 pandemic has been extended and challenged by a constantly changing SARS-CoV-2 virus. One of the biggest challenges is the moving target of pathogenic coronavirus that constantly evolves into new virus strains (variants) with mutations. These new viral strains harbor various changes in the viral protein spike with high infection rates and increased breakthroughs due to vaccine inefficiencies and resistance to therapeutic monoclonal antibodies.

Our studies demonstrate that extracellular vesicles act to neutralize SARS-CoV-2 infection and highlight the potential for extracellular vesicles to play a broader role in defense against other types of infection which could be exploited therapeutically, said co-lead author Kathleen McAndrews, Ph.D., postdoctoral fellow in Cancer Biology at MD Anderson.

Northwestern and MD Anderson have a pending patent on evACE2. The goal is to collaborate with industry partners and develop evACE2 as a biological therapeutic product (nasal spray or injected therapeutics) for prevention and treatment of COVID-19. Liu and another co-senior author, Deyu Fang from pathology at Northwestern, have formed a startup company, Exomira, to take this patent and develop evACE2 as a therapeutic.

It remains urgent to identify novel therapeutics, Liu said. We think evACE2 can meet the challenges and fight against broad strains of SARS-CoV-2 and future emerging coronaviruses to protect the immunocompromised (at least 2.7% of U.S. adults), the unvaccinated (94% in low-income countries and more than 30% in the U.S.) and even the vaccinated from breakthrough infections.

The work was supported by the Chicago Biomedical Consortium Accelerator Award, Northwestern University Feinberg School of Medicine Emerging and Re-emerging Pathogens Program, the National Cancer Institute (IF32CA257345-01, CA060553), the Blood Biobank fund and Lyda Hill Philanthropies (to MD Anderson). Northwesterns pharmacology and pathology departments, Northwestern University Clinical and Translational Sciences Institute and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University also supported the work.

A team of more than 30 authors collaborated on this work. They include four lead co-first authors Lamiaa El-Shennawy, Andrew Hoffmann and Nurmaa Dashzeveg, all from the Liu lab at Northwestern, and McAndrews from the Kalluri Lab of MDAnderson. A full list of collaborating authors and their disclosures can be found here.

The collaboration between Northwestern and MD Anderson was initiated and fostered by co-author Valerie LeBleu, now an MD/MBA student at Feinberg and Kellogg School of Management and formerly an assistant professor of Cancer Biology at MD Anderson.

- 30 -

Nature Communications

20-Jan-2022

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

View original post here:
Nano-sized vesicles with ACE2 receptor could prevent, treat infection from current and future strains of SARS-CoV-2 - EurekAlert

UCSF Aims To Re-Think Neuroscience Research With Its New Building – Forbes

The Joan and Sanford Weill Neurosciences Building at UCSF Mission Bay.

Modern day science tends to be highly interdisciplinary. It increasingly requires different technical topics, skills, and expertise to come together to solve complex and challenging problems and questions. The image of the isolated scientist working alone in their lab for periods on end, emerging only to share a great discovery with the world, is somewhat antiquated. To be sure, doing science even today still necessitates long periods of deep thinking, introspection, and figuratively (occasionally literally) banging your head against the wall. But the tangible output of ones efforts are almost always a piece that fits into a broader scientific context. Collaborators may be working on other parts of the same problem, with everyones work eventually converging into a coherent whole. Or a solution may only emerge as a byproduct of collective brainstorming or the sharing of ideas. All of this, is to say, requires much and very tangible human-human interactions.

The environments - the building, labs, and offices - on university campuses in which all of this research takes place more and more reflect the need to serve these requirements. Architecture, art, and science are progressively more intertwined. Science is, after all, a very social pursuit. The research and public spaces that make up modern universities can be spectacular.

This is the path the University of California San Francisco (UCSF) is attempting to take with the newly opened Joan and Sanford Weill Neurosciences Building. Located on their Mission Bay campus, at just under 283,000 square feet, the building brings together clinical and basic neuroscience treatment and research under one roof. The Departments of Neurology, Neurological Surgery, Psychiatry and Behavioral Sciences, and the Institute for Neurodegenerative Diseases, along with the Weill Institute for Neurosciences and the Neuroscience Graduate Program, will all be housed in this building.

To make this possible, Joan and Sanford Weill made a gift of $185 million to the university, the largest gift in UCSFs history and one of the largest such donations in the country intended to specifically support neuroscience.

Dr. Stephen Hauser, the Robert A. Fishman Distinguished Professor of Neurology and Director of the Weill Institute for Neurosciences, offered his thoughts on the vision for the building and what it will enable.

What was the intended vision for the building and what do you hope it will achieve? Both scientifically and societally.

S.H.: We envisioned the building as a place where patients with difficult brain diseases receive care, where scientists search for answers to these problems, where young people will be inspired to dedicate themselves to careers in research and care, and a building that will also be a magnet for the community to promote interest in neuroscience.

We also needed a building that radiates hope, that reflects the optimism that we feel for the future. More than 60,000 patients annually will be seen in the clinical center, and here a variety of decision support tools and displays for precision medicine have been developed to assist patients and clinicians in tracking individual disease trajectories, contextualizing an individuals function relative to others, and providing evidence-based decision support.

Another key theme was that by breaking down silos across disciplines - across scientific disciplines and even across institutions - we could accelerate research to find answers to terrible brain disorders that affect more than 1 billion people each year. As one example, the distinctions between neurologic and psychiatric disorders of the brain are largely accidents of history, and importantly the same research tools are increasingly used to understand these disorders.So we brought these together. Also, we needed to bring other scientific disciplines, such as engineering, data sciences and imaging sciences, into our neuroscience community to maximize the potential for discovery.

What is perhaps most central is that the research mission will focus on human neuroscience and real human disease.By bringing together outstanding clinician-researchers with basic scientists, ideas gained at the laboratory can rapidly be validated at the bedside, and vice versa. So, a facility that will stimulate this interaction is the secret sauce of the building.

Another goal for this building is to excite the wider community with the exhilarating progress in brain science.What could be more interesting or more important than thinking about how we think?The big ethical issues that are likely to face us in the coming years are by no means restricted to neuroscience, but its in neuroscience that many of these questions come into sharpest focus, whether it be questions of enhancing cognitive or motor skills, computer brain interfaces and the creation of machine-human chimeras, the privacy of our thoughts, or the appropriate use of neuroscience data by the legal system.The stuff of science fiction is soon to become real.

What makes this building, and the environment it will create, unique to do neuroscience research compared to other state of the art buildings at other institutions?

S.H.: I dont think that there is another facility anywhere in the world quite like this - anchored in a huge medical and neuroscience community, focused on the neuroscience of human beings and human disease, and that brings clinical care and clinical research on the real diseases under the same roof as the basic lab investigations.

What is unique about the building and the environment it will create that you anticipate will lead to work and results - e.g. discoveries, technologies - that could not be achieved outside that environment?

S.H.: One of the most exciting developments has been recognition from others who share this vision and have joined us in new partnerships. One superb example is the Weill Neurohub, a close partnership across the neurosciences between UCSF, the University of California Berkeley, and the University of Washington. Another is a large 10 year partnership recently launched with Genentech and Roche, the Alliance for Therapies in Neuroscience, to jointly work together on problems in brain science and development of therapeutics.

Mark Cavagnero, Founding Principal at Mark Cavagnero Associates, the architecture firm that designed the building, provided his perspective on what it took to physically design and build a space that fulfilled UCSFs vision.

MC: Dr. Hausers goals were numerous and complex, though interconnected. It is the interconnected nature of all these goals that gives the building its unique form and singular presence.

The first challenge was to plan and design a building that integrates both clinical care for patients and state of the art research labs for scientists. The ability for scientists to both see patients and participate in their research projects in the same building on the same day was pivotal. The building goals were to not just envision this new form of integrated clinical care and scientific research, but to create a new form of architectural expression which presents that sensibility to everyone who sees it. We needed to fully understand the goal of creating a destination building- a destination for patients, for scientists, for science itself. It was never considered a secure bunker for research, but always seen as a transparent center for ideas, ideas grounded in progress, care, and hope.

How did you balance the aesthetics of the building with its technical and scientific requirements?

M.C. In making a building that attracts young people to dedicate themselves to research and care careers and to be a magnet for the community in a way to promote neuroscience and to radiate hope- the building needed to be beautiful from every angle. I wanted the building to change its feel slightly depending on your vantage point, your angle of view. Beauty is timeless and its own source of wonderment and joy; so creating a building of beauty was a strong desire.

As we understood these goals more and more clearly, it became clear that the building needed to have a unique clarity to it. The building needed to express the rational permanence of science with the all-too- human dynamism of nature. Bringing science and nature, rational thought and human emotion into each space was our challenge. Bringing both sides of the brain into ones awareness of the environment seemed exciting to me, to simultaneously fulfill the needs for abstract thought and tactile perception and feeling.

The human nature of socialization, of impromptu meeting and spontaneous discussion was also discussed at length. Scientists of different background can meet over coffee, lunch, in a meeting room, in a lounge or on the roof terrace overlooking the campus. Excitement and research updates can be shared quickly and personally, with interaction made so easy. The human side of research, once again, is being given great priority. The screens temper the dry and wet labs only. The clinical care and social spaces where scientists mingle- all are clear and exposed to the community. The essential human quality of this endeavor is made manifest even if the research has a veil of protection over it.

The reception from the faculty occupying the new space has been positive. Dr. Riley Bove, Associate Professor of Neurology, expressed how this new environment will be transformational in allowing our work in digital and precision medicine to become a reality for patients seen in the neuropsychiatry clinics. Across our institution, there have been a number of pivotal studies validating the ability to digitally phenotype patients, remotely engage and monitor individuals, and apply complex algorithms to understand human behavior, imaging, and biosamples. To date, individuals including clinicians, engineers, psychologists, physicists, and geneticists have often worked in siloes, focusing on a specific tool, insight, or condition. The new Institute is an opportunity for researchers who have worked on siloed aspects of this research to come together and thread all the rich insights and data back into the clinic in simple, relevant formats, to impact clinical care.

For Dr. Mercedes Paredes, also an Associate Professor in the Department of Neurology, who studies perinatal brain development, a critical period immediately before and after birth that can impact neurodevelopmental disorders such as epilepsy or autism spectrum disorder, the buildingthat will bring diverse expertise in neuroscience includingleaders in cutting edge CRISPR technology, developmental bioinformatic gurus, and neuropathologists and neonatologists. She went on to explain how having this multidisciplinary perspective together will accelerate collaborationand discoveries across many fields. I also think it's special to have this adjacent to the clinical work, in the hopes that each side of the bench-clinic can inspireone another.

Dr. Edward Chang, Professor and Chair of the Department of Neurological Surgery said that the new building is an extraordinary environment for carrying out our researchonhuman brain neural computations. The generous natural light, high ceilings, and open space layout achieve a perfect balance.

Similar comments were made by the other departments who have faculty moving into the new building. Dr. MatthewW.State, Chair of the Department of Psychiatry and Behavioral Sciences said the buildingplaces the basic science of psychiatry literally in the heart of the outstanding UCSF neuroscience community.It advances our shared missionat UCSF of breaking down the arbitrary barriers that have historically separated psychiatry from neurology, neurosurgery and other medical and scientific fields that focusonthe brain. And for S. Andrew Josephson, Chair of Neurology, the newbuilding's combinationof laboratories, clinical research facilities, and computational centers combined with patient-based clinical care including state-of-the-art imaging and neuroinfusionpositions us to quickly translate discoveries into therapies for a group of disorders that urgently need solutions.

It is evident that the new building was architecturally and aesthetically carefully designed to allow the interaction of clinical and basic neuroscience research and care to take place in a harmonious way under one impressive space. It feels like science and medicine taking place literally inside a work of art. Of course, only time will tell how the new building and the work that will take place within will differ from other similar efforts at universities across the world - which no doubt provides challenging competition. Yet, the new UCSF building seems almost purposefully designed to allow the imagination and creativity of its occupants to thrive. Which is after all what is necessary to truly understand and treat the brain.

View post:
UCSF Aims To Re-Think Neuroscience Research With Its New Building - Forbes

Nettles receives award from Society for Neuroscience – The Source – Washington University in St. Louis – Washington University Record

Sabin Nettles, a graduate student in the Department of Neuroscience at the School of Medicine, received the Pre/Postdoctoral Next Generation Award from the Society for Neuroscience in recognition of her outreach work introducing neuroscience to young students through the Brain Discovery initiative.

Read more on the Department of Neuroscience website.

Excerpt from:
Nettles receives award from Society for Neuroscience - The Source - Washington University in St. Louis - Washington University Record

Researchers provide insight into how the brain multitasks while walking – URMC

New research turns the old idiom about not being able to walk and chew gum on its head. Scientists with the Del Monte Institute for Neuroscience at the University of Rochester have shown that the healthy brain is able to multitask while walking without sacrificing how either activity is accomplished.

David Richardson

This research shows us that the brain is flexible and can take on additional burdens, said David Richardson, an MD/PhD student in his fifth year in the Pathology & Cell Biology of Disease Program, and first author of the study recently published in the journal NeuroImage. Our findings showed that the walking patterns of the participants improved when they performed a cognitive task at the same time, suggesting they were actually more stable while walking and performing the task than when they were solely focused on walking.

During these experiments, researchers used a Mobile Brain/Body Imaging system, or MoBI, located in the Del Monte Institutes Frederick J. and Marion A. Schindler Cognitive Neurophysiology Lab. The platform combines virtual reality, brain monitoring, and motion capture technology. While participants walk on a treadmill or manipulate objects on a table, 16 high speed cameras record the position markers with millimeter precision, while simultaneously measuring their brain activity.

Example of image captured by MoBI.

The MoBI was used to record the brain activity of participants as they walked on a treadmill and were cued to switch tasks. Their brain activity was also recorded as they performed these same tasks while sitting. Brain changes were measured between the cued tasks and showed that during the more difficult the tasks the neurophysiological difference was greater between walking and sitting highlighting the flexibility of a healthy brain and how it prepares for and executes tasks based on difficulty level.

The MoBI allows us to better understand how the brain functions in everyday life, said Edward Freedman, Ph.D., lead author on the study. Looking at these findings to understand how a young healthy brain is able to switch tasks will give us better insight to whats going awry in a brain with a neurodegenerative disease like Alzheimers disease.

Edward Freedman, Ph.D.

Understanding how a young healthy brain can successfully walk and talk is an important start, but we also need to understand how these findings differ in the brains of healthy older adults, and adults with neurodegenerative diseases, said Richardson. The next stage is expanding this research to include a more diverse group of brains.

Additional authors include John Foxe, Ph.D., Kevin Mazurek, Ph.D., and Nicholas Abraham of the University of Rochester. This research was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Del Monte Institute for Neuroscience Pilot Program.

See the article here:
Researchers provide insight into how the brain multitasks while walking - URMC

On Meditation and the Unconscious: A Buddhist Monk and a Neuroscientist in Conversation – The MIT Press Reader

An excerpt from "Beyond the Self: Conversations between Buddhism and Neuroscience."

By: Matthieu Ricard & Wolf Singer

Buddhism shares with science the task of examining the mind empirically; it has pursued, for two millennia, direct investigation of the mind through penetrating introspection. Neuroscience, on the other hand, relies on third-person knowledge in the form of scientific observation.

In the following conversation, Matthieu Ricard, a Buddhist monk trained as a molecular biologist, and Wolf Singer, a distinguished neuroscientist, offer their perspectives on the unconscious and the role of meditation in resolving conflicts that arise at levels inaccessible to conscious processing.

The text is excerpted from their book Beyond the Self: Conversations between Buddhism and Neuroscience, a collection of illuminating exchanges Ricard and Singer close friends had over the course of eight years at meetings around the world. Their objective, as they write in the books preface, is to confront two perspectives anchored in rich traditions: the contemplative Buddhist practice, and epistemology and research in neuroscience. The Editors

Matthieu Ricard: Lets explore for a bit the notion of the unconscious, from neuroscientific and contemplative perspectives. Usually when people speak about the unconscious, they refer to something deep in our psyche that we cannot access with our ordinary consciousness. We certainly have the concept, in Buddhism, of habitual tendencies that are opaque to our awareness. These tendencies initiate various thought patterns that can either occur spontaneously or be triggered by some kind of external circumstance. Sometimes you are just sitting there, thinking of nothing in particular, and suddenly the thought of someone or a particular event or situation pops up in the mind, seemingly out of nowhere. From there, a whole chain of thoughts begins to unfold, and if you are not mindful, you can easily get lost in it.

The general public, psychologists, and neuroscientists surely have varying views about what the unconscious is. As for psychoanalysis, what it calls the depths of the unconscious are, from a contemplative perspective, the outer layers of clouds formed by mental confusion that temporarily prevent one from experiencing the most fundamental nature of mind. How can there be something unconscious in a state of pure awareness, devoid of mental construct? No darkness exists in the middle of the sun. For Buddhism, the deepest, most fundamental aspect of consciousness is this sun-like awareness, not the murky unconscious. Of course, this is all expressed from the first-person perspective, and I am sure that a neuroscientist approaching this issue from the third-person perspective will have a different view of the unconscious.

For Buddhism, the deepest, most fundamental aspect of consciousness is [a] sun-like awareness, not the murky unconscious.

Wolf Singer: Yes, I see it a bit differently. As mentioned earlier, an enormous amount of knowledge is stored in the specific architectures of the brain, but we are not aware of most of these given heuristics, assumptions, concepts, and so on. These routines determine the outcomes of cognitive processes, which we are aware of, but the routines remain hidden in the unconscious. Usually we are not aware of the rules that govern the interpretation of sensory signals, the construction of our percepts, or the logic according to which we learn, decide, associate, and act.

We cannot move these implicit hypotheses and rules to the workspace of consciousness by focusing our attention on them, as is possible with contents stored, for example, in declarative memory, the memory in which we store what has been consciously experienced. Abundant evidence indicates that attentional mechanisms play a crucial role in controlling access to consciousness. When attended to, most signals from our senses can reach the level of conscious awareness. Exceptions are certain odors, such as pheromones, that are processed by special subsystems and cannot be perceived consciously. Then there are the many signals from within the body that are excluded from conscious processing, such as messages about blood pressure, sugar level, and so on. It cannot be emphasized enough, however, that signals permanently excluded from conscious processing as well as transitorily excluded signals such as nonattended sensory stimuli still have a massive impact on behavior. In addition, these unconscious signals can control attentional mechanisms and thereby determine which of the stored memories or sensory signals will be attended and transferred to the level of conscious processing.

Another constraint is the limited capacity of the workspace of consciousness. At any one moment in time, only a limited number of contents can be processed consciously. Whether these limitations are due to the inability to attend to large numbers of items simultaneously or whether they result from the restricted capacity of working memory or both is still a matter of scientific investigation. The capacity of the workspace is limited to four to seven different items. This finding corresponds to the number of contents that can be kept simultaneously in working memory. The phenomenon of change blindness, the inability to detect local changes in two images presented in quick succession, demonstrates impressively our inability to attend to and consciously process all features of an image simultaneously.

Perception is actually not as holistic as it appears to be. We scan complex scenes serially, and actually much of what we seem to perceive we are in fact reconstructing from memory. Which of the many signals actually reach the level of conscious awareness is determined by a host of factors, both conscious and unconscious. It depends on what we attend to, and this is controlled by either external cues, such as the saliency of a stimulus, or internal motifs, many of which we may not actually be aware of. Then it may occur that even an attentive, conscious search for content stored in declarative memory fails to raise it to the level of awareness. We are all familiar with the temporary inability to remember an episode or a name and then how a persisting subconscious search process may suddenly lift the content into the workspace of consciousness. It appears that we are not always capable of controlling which contents enter consciousness.

I consider the workspace of consciousness as the highest and most integrated level of brain function. Access to this workspace is privileged and controlled by attention. Moreover, the rules governing conscious deliberations such as consciously made decisions most likely differ from those of subconscious processes. The former are based mainly on rational, logical, or syntactic rules, and the search for solutions is essentially a serial process. Arguments and facts are scrutinized one by one and possible outcomes investigated. Hence, conscious processing takes time. Subconscious mechanisms seem to rely more on parallel processing, whereby a large number of neuronal assemblies, each of which represents a particular solution, enter into competition with one another. Then a winner-takes-all algorithm leads to the stabilization of the assembly that best fits the actual context of distributed activity patterns. Thus, the conscious mechanism is suited best to circumstances in which no time pressure exists, when not too many variables have to be considered, and when the variables are defined with sufficient precision to be subjected to rational analysis. The domains of subconscious processing are situations requiring fast responses or conditions where large numbers of underdetermined variables have to be considered simultaneously and weighed against variables that have no or only limited access to conscious processing, such as the wealth of implicit knowledge and heuristics, vague feelings, and hidden motives or drives.

We scan complex scenes serially, and actually much of what we seem to perceive we are in fact reconstructing from memory.

The outcome of such subconscious processes manifests itself in either immediate behavioral responses or what are called gut feelings. It is often not possible to indicate with a rational argument why exactly one has responded in that way and why one feels that something is wrong or right. In experimental settings, one can even demonstrate that the rational arguments given for or against a particular response do not always correspond to the real causes. For complex problems with numerous entangled variables, it often turns out that subconscious processes lead to better solutions than conscious deliberations because of the wealth of heuristics exploitable by subconscious processing. Given the large amount of information and implicit knowledge to which consciousness has no or only sporadic access and the crucial importance of subconscious heuristics for decision making and the guidance of behavior, training oneself to ignore the voices of the subconscious would not be a helpful, well-adapted strategy.

MR: What you said corresponds with what Daniel Kahneman explains in his book Thinking, Fast and Slow. Although we are generally convinced that we are rational, our decisions, economic or otherwise, are often irrational and strongly influenced by our immediate gut feelings, emotions, and situations to which we have been exposed immediately before taking a decision. Intuition is a highly adaptable faculty that allows us to make fast decisions in complex situations, but it also lures us into thinking that we have made a rational choice, which actually takes more time and deliberation.

I understand that a lot is going on in the brain to allow us to function and have coherent perceptions, memories, and so on. But I was thinking more of the pragmatic aspect of dealing with the particular tendencies that give rise to the afflictive mental states and emotions associated with suffering. My point was that if you know how to relate to pure awareness and rest within that space of awareness, when disturbing emotions arise, they dissolve as they appear and do not create suffering. If one is an expert in this, then there is no need to bother about what is going on down in the subconscious. It is more a question of method. Psychoanalysis, for instance, contends that you need to find a way to dig into those hidden impulses and identify them, whereas Buddhist meditation teaches you to free the thoughts as they arise.

By dwelling in the clarity of the present moment, you are free from all ruminations, upsetting emotions, frustrations, and other inner conflicts. If you learn to deal, moment after moment, with the arising of thoughts, then you can preserve your inner freedom, which is the desired goal of such training.

WS: Here we seem to face rather divergent concepts of the virtues of subconscious processing and the way we should deal with the unconscious dimension of our mind. This brings me to a critical issue: the side effects of meditation. One could argue that a strategy consisting of closing ones eyes when facing conflicts, in escaping from problems rather than solving them, is perhaps a suboptimal strategy. Let us assume that conflicts exist in the subconscious and that the rumination motivated by these conflicts serves to identify and settle them. Such conflicts could arise from ambiguous bonding between the child and her caretaker in early infancy or from conflicting imperatives imprinted by early education. The causes of such problems cannot easily surface in consciousness because they are part of implicit memories that have been formed prior to the maturation of declarative memory. Such conflicts jeopardize mental and physical health.

Humankind throughout its history has sought relief from such problems, with drugs, cultural activities, and, more recently, a host of specially designed therapies. Most of the latter require one to face the problem to cope with it. Another strategy, which is applied in cognitive and behavioral therapy, attempts to alleviate the problem by unlearning the habit using conditioning paradigms. If one suffers from a particular phobia, then one gets exposed to the threatening events and learns that they dont cause harm, and after a while, one habituates to the threat and the problem may be solved.

MR: We surely need to get at the heart of the issue. But in the end, what we need is to be free from inner conflicts, one way or another, right? So, there might be ways that involve digging into the past as much as one can, with or without the help of a therapist, and then trying to solve the problem or trauma that has thus been identified, thereby freeing oneself from the afflictive effect. But there are also ways, including those used by Buddhism, that do not attempt to elude the problem but to free any conflicting thoughts that arise in the mind at the moment they arise. If you become expert in those methods, the so-called afflictive thoughts no longer have the power to afflict you because they undo themselves the moment they arise. But that is not all: Experience shows that by repeatedly doing so, you not only deal successfully with each individual arising of afflictive thoughts but you also slowly erode the tendencies for such thoughts to arise. So in the end, you are free of them entirely. Among contemporary Western therapies, cognitive and behavioral therapy also offer methods to attend precisely to a particular emotion that upsets you in the moment and deal with it in a reasonable and constructive way and has therefore some interesting similarities with the Buddhist approach.

WS: Let us see what meditation could contribute to the resolution of conflicts that arise at levels inaccessible to conscious processing. I shall take a critical stance and use a real-world problem as an example. Imagine a conflict evolves between two partners that evokes uneasy feelings and causes lasting mental rumination in both parties. Their two ego bubbles fight against each other, as in Whos Afraid of Virginia Woolf? Love and passion exist between them, which are both difficult to control because they are anchored in subconscious spheres. The partners go into retreat and meditate, stop ruminating, and feel fine while they meditate alone in a protected environment. But will this solve the problem? Will they not resume fighting once they are back home, together, and confronted again with their problems?

MR: To openly confront our differences can be a way to pacify a conflict, but it is not the only one. To begin with, a conflict requires two protagonists confronting each other in antagonistic ways. One cannot clap with one hand only. In fact, if one of the persons involved disarms his or her own antagonistic mind, then it will contribute greatly to reducing the conflict with the other person.

We did an experiment at Berkeley with Paul Ekman and Robert Levenson, who, among other things, have been studying conflict resolution. In this case, they wanted me to have two conversations with two different people. The idea was to discuss a controversial topic in this case, why a former biologist like me, who did research in a prestigious lab at Pasteur Institute, would ever choose not only to become a Buddhist monk but to believe in crazy things such as reincarnation. We were all fitted with all kinds of sensors detecting our heart rate, blood pressure, breathing, skin conductivity and sweating, and body movements, and our facial expressions were recorded on a video camera, to be later analyzed in details for fleeting microexpressions. My first interlocutor was Professor Donald Glaser, a Nobel laureate in physics, who then moved to research in neurobiology. He was an extremely kind and open-minded person. Our discussion went well, and at the end of the 10 minutes, we both regretted not having more time to dialogue. Our physiological parameters indicated a calm, nonconflictual attitude. Then came in someone who had to be chosen because he was reputed to be a rather difficult person he was not told about that of course! He knew that we were supposed to get into a heated debate and went straight into it. His physiology became immediately highly aroused. From my side, I tried my best to remain calm I actually enjoyed it and did my best to provide reasonable answers delivered in a friendly way. Soon enough, his physiology became calmer and calmer, and at the end of the 10 minutes, he told the researchers, I cant fight with this guy. He says reasonable things and smiles all the time. So, as the Tibetan saying goes, One cannot clap with one hand.

As far as your own inner conflicts are concerned, if you use meditation simply as a quick fix to superficially appease your emotions, you temporarily enjoy a pleasant deferral of these inner conflicts. But as you rightly say, these cosmetic changes have not reached the root of the problem.

Merely putting problems to sleep for a while or trying to forcibly suppress strong emotions will not help either. You are just keeping a time bomb ticking somewhere in a corner of your mind.

True meditation, however, is not just taking a break. It is not simply closing ones eyes to the problem for a while. Meditation goes to the root of the problem. You need to become aware of the destructive aspect of compulsive attachment and all of the conflictive mental states that you mentioned. They are destructive in the sense of undermining your happiness and that of others, and to counteract them you need more than just a calming pill. Meditation practice offers many kinds of antidotes.

A direct antidote is a state of mind that is diametrically opposed to the afflictive emotion you want to overcome, such as heat and cold. Benevolence, for instance, is the direct opposite of malevolence because you cannot wish simultaneously to benefit and harm the same person. Using this kind of antidote neutralizes the negative emotions that afflict us.

Lets take the example of desire. Everyone would agree that desire is natural and plays an essential role in helping us to realize our aspirations. But desire in itself is neither helpful nor harmful. Everything depends on what kind of influence it has over us. It is capable of both providing inspiration in our life and poisoning it. It can encourage us to act in a way that is constructive for ourselves and others, but it can also bring about intense pain. The latter occurs when desire is associated with grasping and craving. It then causes us to become addicted to the causes of suffering. In that case, it is a source of unhappiness, and there is no advantage in continuing to be ruled by it. Here you may apply the antidote of inner freedom to the desire that causes suffering. You bring to your mind the comforting and soothing quality of inner freedom and spend a few moments allowing a feeling of freedom to be born and grow in you.

True meditation is not just taking a break. It is not simply closing ones eyes to the problem for a while. Meditation goes to the root of the problem.

Because desire also tends to distort reality and project its object as something that you cannot live without, to regain a more accurate view of things, you may take the time to examine all aspects of the object of your desire and see how your mind has superimposed its own projections onto it. Finally, you let your mind relax into the state of awareness, free from hope and fear, and appreciate the freshness of the present moment, which acts like a balm to soothe the burning of desire. If you do that repeatedly and perseveringly and this point is really the most important this will gradually lead to a real change in the way you experience things all the time.

The second, even more powerful way to deal with afflictive emotions is to stop identifying with them: You are not the desire, you are not the conflict, and you are not the anger. Usually we identify with our emotions completely. When we become overwhelmed by desire, anxiety, or a fit of anger, we become one with it. It is omnipresent in our mind, leaving no room for other mental states such as inner peace, patience, or reasoning, which might calm our torments.

The antidote is to be aware of desire or anger, instead of identifying with it. Then the part of our mind that is aware of anger is not angry, it is simply aware. In other words, awareness is not affected by the emotion it is observing. Understanding that makes it possible to step back and realize that the emotion is actually devoid of solidity. We just need to provide an open space of inner freedom, and the internal affliction will dissolve by itself.

By doing so, we avoid two extremes, each as inefficient as the other: repressing our emotion, which would then remain as powerful as before, or letting the emotion flare up, at the expense of those around us and of our own inner peace. Not to identify with emotions is a fundamental antidote that is applicable to all kinds of emotions in any circumstance.

This method might seem difficult at the beginning, especially in the heat of the moment, but with practice, it will become easier to retain mastery of your mind and deal with the conflicting emotions of day-to-day life.

Matthieu Ricard, a Buddhist monk, trained as a molecular biologist before moving to Nepal to study Buddhism. He is the author of several books, including The Monk and the Philosopher (with his father, Jean-Franois Revel); The Quantum and the Lotus (with Trinh Xuan Thuan); The Art of Meditation; and Beyond the Self: Conversations between Buddhism and Neuroscience (with Wolf Singer), from which this article is excerpted. The MIT Press will publish the English translation of his memoir, Notebooks of a Wandering Monk, next fall.

Wolf Singer is Emeritus Director of the Max Planck Institute for Brain Research and Founding Director of the Frankfurt Institute for Advanced Studies and the Ernst Strngmann Institute for Neuroscience in cooperation with the Max Planck Society, where he is also Senior Research Fellow.

View original post here:
On Meditation and the Unconscious: A Buddhist Monk and a Neuroscientist in Conversation - The MIT Press Reader

What to Expect in Neuroscience, Genetics, Longevity, Biotech, and Psychedelics in 2022 – NEO.LIFE

Why do I have to complete a CAPTCHA?

Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.

If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.

If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices.

Another way to prevent getting this page in the future is to use Privacy Pass. You may need to download version 2.0 now from the Firefox Add-ons Store.

Continue reading here:
What to Expect in Neuroscience, Genetics, Longevity, Biotech, and Psychedelics in 2022 - NEO.LIFE

Dr. Qin Wang will lead new Program for Alzheimer’s Therapeutics Discovery at MCG – Jagwire Augusta

Dr. Qin Wang, an expert in molecular neuropharmacology and signaling research exploring how cell surface receptor signaling regulates healthy brain function and contributes to neurological and psychiatric disorders, has been named the inaugural director of the Program for Alzheimers Therapeutics Discovery at the Medical College of Georgia.

The Alzheimers Association tells us that more than six million Americans already are living with this devastating problem, a number that is likely to more than double in the next few decades, says Dr. David Hess, MCG dean. With great support from the Georgia Research Alliance, Dr. Wang will enable us to more strategically address this pervasive condition generally associated with aging and help us identify better therapeutic and prevention strategies that improve peoples lives.

Qin Wang is a superstar who has already moved the needle significantly in Alzheimers research, says GRA President Susan Shows. She has deepened understanding of the toxic cascade in the brain that contributes to the disease, and she has discovered new avenues for treatments. Georgia is fortunate to add her great breadth and depth in pharmacology to our university research portfolio.

Wang joins the faculty of the MCG Department of Neuroscience and Regenerative Medicine April 1. She is an MD/PhD who completed her postdoctoral studies in pharmacology at Vanderbilt University, joined the faculty there then moved to the University of Alabama at Birmingham in 2005 where she is currently a professor in the Department of Cell, Developmental and Integrative Biology.

She is a member of the American Heart Association Councils on Basic Cardiovascular Sciences and High Blood Pressure Research. She has served as a regular member of the National Institutes of Health and AHA Molecular Peer Review Study Groups. Wang also has served as a grant reviewer for the Alzheimers Association for more than a decade and has served on the Scientific Advisory Board of the Alzheimers Disease Congress and on the Executive Committee of the American Society for Pharmacology and Experimental Therapeutics Molecular Pharmacology Division. She is permanent associate editor for neurodegeneration for the journal Frontiers in Neuroscience.

Dr. Wang is currently principal investigator on three National Institutes of Health grants and contact PI on two additional multi-PI NIH grants. She was among the top 20 out of 869 NIH-funded PIs in the nations anatomy/cell biology departments in 2020.

LikeLoveHahaWowSadAngry

Continue reading here:
Dr. Qin Wang will lead new Program for Alzheimer's Therapeutics Discovery at MCG - Jagwire Augusta

NTT Research to Collaborate with Researchers at Harvard University on Computational Neurobiology – Business Wire

SUNNYVALE, Calif.--(BUSINESS WIRE)--NTT Research, Inc., a division of NTT (TYO:9432), today announced that it has entered a joint research agreement with scientists at Harvard University to study animal neuro-responses with the hope of informing future artificial intelligence systems. The five-year research project, launched in the fall of 2021, enables researchers at the two organizations to collaboratively study how animals maintain behavioral flexibility, specifically in the task of navigation. Greater understanding of how this challenge is approached in biology may eventually enable the design of new computing machines with similar capabilities. The principal investigator is Venkatesh Murthy, PhD, the Raymond Leo Erikson Life Sciences Professor of Molecular and Cellular Biology at Harvard and the Paul J. Finnegan Family Director of its Center for Brain Science. Murthys counterpart at NTT Research for the joint project is Physics & Informatics (PHI) Lab Research Scientist Gautam Reddy, PhD, who was previously an Independent Post-Doctoral Fellow at Harvards NSF-Simons Center for Mathematical and Statistical Analysis of Biology.

This joint research aims to better elucidate how animals maintain the ability to respond appropriately to a wide variety of complex real-world scenarios. The investigators expect the results from one aspect of the research to be a source of new, biologically inspired ideas for artificial reinforcement learning systems that rely on representation learning. Such ideas have played a major role in recent advances in artificial intelligence. Results from another aspect of the research should provide a quantitative understanding of how animals track trails, as well as identify the basic elements of general behavioral strategies that perform flexibly and reliably in the real world. Professor Murthys lab has a long track record in experimental and computational neurobiology. Expertise relevant to the joint research includes the ability to record from or image many individual neurons in the brain while an animal performs behavioral tasks. This technical expertise will enable the research team to understand what computations are performed by biological neural networks when an animal is navigating in a complex world.

Efficient computation is at the heart of quantum computing and neuroscience. Inspired by neuroscience, recent advances in machine learning have recently begun to change how we process data, said PHI Lab Director Yoshihisa Yamamoto, PhD. This joint research project could provide a rich source of animal-inspired algorithms that generalize across various research domains within NTT and inspire truly novel interdisciplinary ideas.

Professor Murthy and Dr. Reddy have previously worked together on understanding the computational principles behind olfaction. Their focus was on how the smell receptors in the nose respond to blends of odorous compounds. As an Independent Fellow at Harvards NSF-Simons Center for Mathematical Biology, Dr. Reddy worked on the theory behind how animals track scent trails and on developing a computational framework to explain how evolution optimizes organisms. I am delighted to continue this line of inquiry with Dr. Reddy through the NTT Research PHI Lab, Murthy said. The brain is an example of an extremely efficient computational device, and plenty of phenomena within it remain unexplored and unexplained. We believe the results of these investigations in neurobiology will reveal basic understandings and prove useful in the field of artificial intelligence.

Gaining insights from neuroscience is an ongoing part of the PHI Labs strategy to redesign artificial computers. In July 2021, for instance, NTT Research announced a joint research agreement with the University of Tokyos International Research Center for Neurointelligence (IRCN) to develop numerical tools and a simulator for the coherent Ising machine (CIM), an information processing platform based on photonics oscillator networks. In October 2020, PHI Lab Director Yamamoto co-authored a paper in Applied Physics Letters (APL) titled, Coherent Ising Machines: Quantum optics and neural network perspectives, which underscored the interdisciplinary nature of the PHI Labs pathbreaking research agenda, which could lead to a new field of study.

In addition to the researchers at Harvard and the University of Tokyo, investigators at eight other universities have agreed to conduct joint research with the NTT Research PHI Lab. These include the California Institute of Technology (Caltech), Cornell University, Massachusetts Institute of Technology (MIT), Notre Dame University, Stanford University, Swinburne University of Technology, the University of Michigan and the Tokyo Institute of Technology. The NASA Ames Research Center in Silicon Valley and 1QBit, a private quantum computing software company, have also entered joint research agreements with the PHI Lab.

About NTT Research

NTT Research opened its offices in July 2019 as a new Silicon Valley startup to conduct basic research and advance technologies that promote positive change for humankind. Currently, three labs are housed at NTT Research facilities in Sunnyvale: the Physics and Informatics (PHI) Lab, the Cryptography and Information Security (CIS) Lab, and the Medical and Health Informatics (MEI) Lab. The organization aims to upgrade reality in three areas: 1) quantum information, neuroscience and photonics; 2) cryptographic and information security; and 3) medical and health informatics. NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion.

NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and/or its affiliates. All other referenced product names are trademarks of their respective owners. 2022 NIPPON TELEGRAPH AND TELEPHONE CORPORATION

More here:
NTT Research to Collaborate with Researchers at Harvard University on Computational Neurobiology - Business Wire

Hibbs honored with Hackerman Award for work on structure and function of receptors in the brain – UT Southwestern

Neuroscientist Ryan Hibbs, Ph.D., has been honored for his work on structure and function of receptors in the brain.

DALLAS Jan. 19, 2022 UTSouthwestern structural biologist and neuroscientist Ryan Hibbs, Ph.D., has received a 2022 Norman Hackerman Award in Chemical Research. The prize recognizes his work investigating the structure and function of receptors on the surfaces of brain cells and how they interact with drugs, such as nicotine or general anesthetics.

Dr. Hibbs, Associate Professor of Neuroscience and Biophysicsand a member of the Peter ODonnell Jr. Brain Institute, is one of two Hackerman Award winners this year and the ninth UTSouthwestern researcher to receive the prestigious prize since its establishment in 2002. Dr. Guihua Yu of UT Austin was selected for his work in nanomaterial science.

The Welch Foundation, one of the nations oldest and largest sources of private funding for basic research in chemistry, presents the $100,000 award annually to a rising star at a Texas institution. The award is named after the late Norman Hackerman, Ph.D., an internationally known chemist, former president at UT Austin and Rice University, and longtime Chair of the foundations Scientific Advisory Board.

I was blown away and extremely grateful to find out that I had won one of this years Hackerman Awards. I know some of the previous awardees and their work, and it is an honor to be considered a part of that exceptionally high caliber of scientists, said Dr. Hibbs, an Effie Marie Cain Scholar in Medical Research.

My very first research grant came from The Welch Foundation, and it allowed me to take more risks, hire a postdoctoral fellow, and do more in my lab, but it also gave me assurance that an external committee thought my work was exciting enough to support. The Welch Foundation has been immensely helpful in supporting me financially and giving me confidence to succeed, he added.

The award recognizes Dr. Hibbs important contributions to better understand synaptic ligand-gated ion channels, a type of cell-surface receptor present on neurons. These protein receptors act as locks that are opened by molecular keys, either natural chemicals or synthetic pharmaceuticals. In particular, the Hibbs lab has studied receptors that bind nicotine the addictive component in tobacco as well as general anesthetics and the benzodiazepine class of anti-anxiety drugs. He has also studied receptors that bind natural neurotransmitters.

Ryan Hibbs is clearly one of the rising stars in the structural biology and biophysics of neuronal ionotropic receptors. His recent discoveries solving the structures of the nicotinic acetylcholine receptors and the GABAA receptor are landmark accomplishments. Perhaps most stunning historically is the structure of the native nicotinic receptor from the fish electric organ, which was the very first neurotransmitter receptor to be described by neuroscience pioneer Jean-Pierre Changeux over 50 years ago, said Joseph Takahashi, Ph.D., Professor and Chair of Neuroscience, a Howard Hughes Medical Institute (HHMI) Investigator, and holder of the Loyd B. Sands Distinguished Chair in Neuroscience at UTSW.

An important first step in understanding the workings of these channels is to visualize them at high magnification and resolution, Dr. Hibbs explained. He added that UTSouthwesterns decision to invest in a technology known as cryo-electron microscopy (cryo-EM) an imaging system that allows visualization of proteins at the atomic level by freezing them in place has been key to his labs success in this field. Dr. Hibbs wife, Colleen Noviello, Ph.D., is a Senior Research Scientist at UTSouthwestern and has collected most of the cryo-EM data for the Hibbs lab.

Ryan possesses a powerful combination of creativity, fearlessness, technical excellence and superb scientific taste. These have allowed him and his group to determine some of the most important structures in molecular neuroscience, said Michael Rosen, Ph.D., Professor and Chair of Biophysics and an HHMI Investigator. Dr. Rosen also holds the Mar Nell and F. Andrew Bell Distinguished Chair in Biochemistry at UTSW. His work has deepened our understanding of basic functions of the brain and opened the door to improved therapeutics for human conditions spanning mental illness to insomnia.

UTSWs eight current and former scientists who received Hackerman Awards include:

About UTSouthwestern Medical Center

UTSouthwestern, one of the nations premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institutions faculty has received six Nobel Prizes and includes 25 members of the National Academy of Sciences, 16 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UTSouthwestern physicians provide care in about 80 specialties to more than 117,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 3 million outpatient visits a year.

Read more:
Hibbs honored with Hackerman Award for work on structure and function of receptors in the brain - UT Southwestern

This Entrepreneur And Author Says Inner Happiness Should Top Your List – Forbes

To borrow from Aristotle, Happiness is the meaning and the purpose of lifethe whole aim and end of human existence.

For author and entrepreneur Tia Graham happiness is the secret sauce to thriving in business and life.

After she had her second daughter and returned to work as director of sales and marketing at The London West Hollywood Hotel, she was not happy. I was attempting to balance my executive career, motherhood, marriage, friendships, physical health, family, and all else. I felt as if I were failing at all of it, says Graham. I was stressed, overwhelmed, full of guilt, angry, sad and felt stuck.

Tia Graham

While Graham, like many others, had painful and challenging moments in her life before going back to when she was a child, at this moment when she was returning to work, she was particularly unhappy. I thought that maybe it would be my new normal, she shares. I have always been a very positive and optimistic person and have made choices to increase my happiness and well-being. But this thought terrified me.

Being miserable impacted every part of Grahams personal and professional life. At this low point she began researching happiness and the science of happiness. She turned to Tal Ben-Shahar, PhD who taught the popular Positive Psychology course at Harvard University. Graham received a certificate in Happiness Studies and Teaching Happiness Ben-Shahars Happiness Studies Academy. She became certified in neuroscience from The Neuroscience School and is now a speaker and coach at the annual World Happiness Summit.

My neuroscience and positive psychology research gave me the scientific knowledge on why happiness is vital, says Graham. Happiness affects our longevity, relationships, motivation, career and parenting success, creativity, productivity, and more. It connects to everything.

To that end, four years ago Graham made a big career pivot and founded her company Arrive At Happy. With a mission is to inspire transformation through the science of happiness and neuroscience, Graham partners with organizations and leaders to grow their business through a happy, joyful culture.

This month Graham debuted her book, Be a Happy Leader: Stop Feeling Overwhelmed, Thrive Personally, and Achieve Killer Business Results. The book delves into the struggle of feeling overwhelmed and stressed. It offers doable strategies on how to find consistent joy while keeping motivated.

The truth is that our happiness and creating a happy life is an inside job, says Graham. Human connection is the number one predictor of happiness, but there is so much more to it like being resilient, having a healthy relationship with difficult emotions, living with gratitude, learning and growing constantly and giving and helping others. It takes effort and making the ongoing choice to choose to be happy.

Jeryl Brunner: Can you share more how money doesn't make you happy?

Tia Graham: Research shows that wealthy people are happier than less wealthy people. But the degree is a lot smaller than most people would think. A lot of very wealthy people are miserable. Money alone cannot make you happy. What money affords are more choices and time affluence. How you spend your money also contributes to your well-being, like spending on others or experiences rather than material possessions. There is an interesting phenomenon calledThe Hedonic Treadmill from Dr. Martin Seligman. His research shows that once we make a decent living and have all our needs met, a new car or expensive handbag, for example, will give us ahappy high for just three to four months. And then we go back to our resting level of happiness.

Brunner: You write that there are misconceptions about what makes us happy. What are some of those myths?

Graham: One myth is that if you are famous, you will be happier. Another is that when you acquire new material possessions, you will be happier. The research shows that, on average, fame makes us less happy. Another myth is that if you are successful and have a great title, that will make you happy. Another one could be that if you find the love of your life, you will be happy.

Brunner: What inspired you to write Be A Happy Leader?

Graham: I worked as a director of sales and marketing in the luxury hotel industry for 14 years in Hawaii, New York City, Istanbul, and Los Angeles. During that time, I was exposed to motivational and fantastic leaders. I also experienced the exact opposite. I was thrown into a leadership position at 26 years old and always saw leadership as an honor and a big responsibility. I prided myself on being a very positive, supportive, and collaborative leader and created connected, loyal, and successful sales teams.

Over the past five years running my company, Arrive At Happy, I have become certified in positive psychology and applied neuroscience. I created an eight-step methodology to be a happy leader combining my experience and research. A tremendous amount of proven, practical tools exists that all people can use immediately. I knew that I would not be able to reach every person around the world with my talks and leadership programs. My goal is to motivate and educate as many people as possible.

Link:
This Entrepreneur And Author Says Inner Happiness Should Top Your List - Forbes